Large-scale testing (Phase 3)Study completedNCT01304498
What this trial is testing
Immunogenicity and Tolerability of V503 Versus GARDASIL (V503-009)
Who this might be right for
Human Papillomavirus
Merck Sharp & Dohme LLC 600
Showing 20 of 0 results